Psychological interventions for people with Parkinson’s disease in the early 2020s: Where do we stand?
Nicolò Zarotti(Lancaster University), Jane Simpson(Lancaster University), Fiona Eccles(Lancaster University), Andrew Paget(Queen Mary University of London), Sarah Gunn(University of Leicester), Jennifer A. Foley(Queen Mary University of London), Iracema Leroi(Trinity College Dublin)
Cited by 71
Related Papers
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223
Impact of the COVID-19 Pandemic on Loneliness and Social Isolation: A Multi-Country Study
|International Journal of Environmental Research and Public Health|2021|208